1.7  -0.9 (-34.62%)		10-24 15:02
Open: 1.93 High: 1.99 Volume: 65,314,479		Pre. Close: 2.6 Low: 1.48 Market Cap: 26(M)

Short term
Mid term
Targets	6-month :	3.03	1-year :	3.54
Resists	First :	2.59	Second :	3.03
Pivot price	0.87
Supports	First :	1.27	Second :	0.46
MAs	MA(5) :	1.18	MA(20) :	0.86
	MA(100) :	1.25	MA(250) :	2.82
MACD	MACD :	0.1	Signal :	-0.1
%K %D	K(14,3) :	58.8	D(3) :	36.4
RSI	RSI(14): 63.2
52-week	High :	9.55	Low :	0.46

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ SCNX ] has closed below upper band by 10.0%. Bollinger Bands are 211.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	2.6 - 2.61	2.61 - 2.63
Low:	0.82 - 0.82	0.82 - 0.82
Close:	2.58 - 2.6	2.6 - 2.62

TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.

Fri, 24 Oct 2025
Unexpected Surge: SCNX Defies Predictions - StocksToTrade

Fri, 24 Oct 2025
SCNX Stocks Surge: Unexpected Gains Require Attention - timothysykes.com

Fri, 24 Oct 2025
Scienture Shares Skyrocket 350% on FDA-Approved Drug Launch – What’s Next? - ts2.tech

Thu, 23 Oct 2025
INTC, SCNX, F, DECK, SMCI: 5 Trending Stocks Today - Intel (NASDAQ:INTC) - Benzinga

Thu, 23 Oct 2025
Scienture Holdings Stock Is Soaring Thursday: What's Fueling The Momentum? - Benzinga

Thu, 23 Oct 2025
Scienture Holdings (SCNX) Stock Skyrockets on FDA Drug Launch – Will the Rally Last? - ts2.tech

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Shares Out	0 (M)
Shares Float	19 (M)
Held by Insiders	1.162e+007 (%)
Held by Institutions	25.3 (%)
Shares Short	130 (K)
Shares Short P.Month	0 (K)

EPS	-1.644e+007
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-12 %
Return on Assets (ttm)	824.7 %
Return on Equity (ttm)	-19.7 %
Qtrly Rev. Growth	128200 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0.5 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-13 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	421350
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.